₹ 2,667.21 Cr
2.01%
S&P BSE Healthcare TRI
INF200K01446
5000.0
1000.0
500
Tanmaya Desai, Pradeep Kesavan
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 51.56 | 16.41 | 25.56 |
S&P BSE Healthcare TRI | 54.47 | 14.49 | 22.72 |
Equity
Debt
Others
The scheme seeks maximum growth opportunities through investments in Pharma stocks.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.52 |
Max Healthcare Institute Ltd. | 7.56 |
Cipla Ltd. | 6.51 |
Divi's Laboratories Ltd. | 6.0 |
Lonza Group Ag | 5.2 |
Mankind Pharma Ltd. | 4.96 |
Aether Industries Ltd. | 4.37 |
Jupiter Life Line Hospitals Ltd. | 4.01 |
Lupin Ltd. | 3.95 |
Aurobindo Pharma Ltd. | 3.89 |
Sector | Holdings (%) |
---|---|
Healthcare | 93.36 |
Chemicals | 4.37 |
Others | 2.02 |
Materials | 0.25 |
Scheme Name | 5Y (%) |
---|---|
SBI HEALTHCARE Opportunities Reg Gr | 25.56 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 26.23 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 24.12 |
Nippon India Pharma Fund Gr Gr | 25.26 |
DSP Healthcare Reg Gr | 27.15 |
UTI Healthcare Reg Gr | 23.08 |
Mirae Asset Healthcare Reg Gr | 25.59 |
LIC MF Healthcare Fund Reg Gr | 20.02 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |